Inspire Medical Systems (INSP)

Overall impact
B (68)

Commentary

Inspire Medical Systems is a strong overall performer. With a 'B' rating of 68.2 for overall impact (79th percentile compared to all companies), Inspire Medical Systems ranks 64th out of 155 industry peers, behind American Shared Hospital Services, Accuray, BioSig Technologies and 60 others, and ahead of Hologic, Avinger, Adm Tronics Unlimited and 88 others. On top material causes for Inspire Medical Systems's industry (Healthcare Equipment), Inspire Medical Systems performs well in Reduced Green House Gas Emissions (83.5 score), Improved Mental Health (95.2), Sustainable Use of Natural Resources (85.1) and 2 other causes where it received an 'A' score and performs poorly in Humane Treatment of Animals (31.8 score) and Disaster Readiness and Effective Aid (38.6).
Impact
Cause INSP
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
1,333
Sector
Health Care
Industry
Health Care Equipment & Supplies
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Mn, United States
Share classes
INSP
Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers the Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Material causes
Ethos considers the following causes material for Inspire Medical Systems, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.